Ticker

Vancouver, British Columbia--(Newsfile Corp. - September 4, 2026) - The Precision Peptide Company Inc. (CSE: BPC) (OTCQB: PNGAF) (the "Company") announces that on July 31, 2026, it has authorized the grant of restricted share units (the "RSUs") and incentive stock options (the "Options") pursuant to the Company's omnibus share incentive plan (the "Plan"). The Company has granted 150,000 RSUs and 200,000 Options to a…

Highlights The Company's supplement range, led by The Recovery Patch, will be available for purchase on site at FitExpo Anaheim, August 29 and 30, 2026 A 15% event discount will be available to attendees on purchases at booth 750, Anaheim Convention Center The Recovery Patch, the Company's needle-free transdermal peptide patch, achieved 95.5% chromatographic purity and a quantified 2.02 mg dose per patch in…

Vancouver, British Columbia--(Newsfile Corp. - August 19, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or

Vancouver, British Columbia--(Newsfile Corp. - August 7, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announced that it has completed the migration of the Amino Innovations online supplement store www.aminoinnovations.com (the "Amino Innovations Store"), including its…

Highlights The Company introduces expected launch of the Peptide Pen, its second commercial product, marking a significant expansion beyond transdermal patches into precision injection delivery Designed, manufactured, and tested in the United States in a cGMP-certified facility using medical-grade materials Features a 5mL dosing configuration, a first for a combined pen-and-vial peptide device, offering…